Inventor · disambiguated record
Charles Mackay
Also filed as: MACKAY CHARLES · MACKAY CHARLES R · MACKAY CHARLES REAY
30 granted patents·28 pending applications·402 citations·filing 1995–2025
97Inventor score
Files withMILLENNIUM PHARM INC19UNIV MONASH13MACKAY CHARLES REAY6BRIGHAM & WOMENS HOSPITAL2CHILDRENS MEDICAL CENTER2
Top patents by PatentIndex Score
58 records- 0192US8221757B2Monoclonal antibodies against extracellular loops of C5aRMACKAY CHARLES REAY·Filed 2011·Granted Jul 17, 2012·15 cites·28 claims
- 0291US6184358B1IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use thereforMILLENNIUM PHARM INC·Filed 1997·Granted Feb 6, 2001·63 cites·47 claims
- 0389US8268972B2Humanized anti-C5aR antibodiesWHITFELD PETER·Filed 2009·Granted Sep 18, 2012·26 cites·7 claims
- 0489US6528625B1Anti-CCR5 antibodies and kits comprising sameMILLENNIUM PHARM INC·Filed 1997·Granted Mar 4, 2003·100 cites·36 claims
- 0588US8361468B2Humanized anti-C5aR antibodiesG2 INFLAMMATION PTY LTD·Filed 2012·Granted Jan 29, 2013·15 cites·22 claims
- 0688US8337852B2Anti-C5aR antibodies with improved propertiesMACKAY CHARLES REAY·Filed 2007·Granted Dec 25, 2012·12 cites·18 claims
- 0787US8071096B2Anti-C5aR antibodies and uses thereofMACKAY CHARLES REAY·Filed 2003·Granted Dec 6, 2011·20 cites·67 claims
- 0885US8673305B2Methods of treatment with antibodies against the extracellular loops of C5aRMACKAY CHARLES REAY·Filed 2012·Granted Mar 18, 2014·6 cites·21 claims
- 0983US8084024B2Method for producing antibodiesMACKAY CHARLES REAY·Filed 2007·Granted Dec 27, 2011·6 cites·11 claims
- 1081US8808701B2Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodiesG2 INFLAMMATION PTY LTD·Filed 2012·Granted Aug 19, 2014·6 cites·20 claims
- 1180US7407655B2Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibodyMILLENNIUM PHARM INC·Filed 2002·Granted Aug 5, 2008·8 cites·77 claims
- 1278US7423129B2Antibodies to human eotaxinMILLENNIUM PHARM INC·Filed 2007·Granted Sep 9, 2008·1 cites·10 claims
- 1376US8071839B2Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and useMACKAY CHARLES REAY·Filed 2004·Granted Dec 6, 2011·15 cites·17 claims
- 1476US6537764B1Method of identifying inhibitors of C—C chemokine receptor 3CHILDRENS MEDICAL CENTER·Filed 1996·Granted Mar 25, 2003·28 cites·83 claims
- 1573US2010061983A1Method of inhibiting leukocytes with human cxc chemokine receptor 3 antibodyMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1673US2021244692A1Metabolites for treatment and prevention of autoimmune diseaseUNIV MONASH·Filed 2021·Application pending·0 cites
- 1772US7012133B1Antibodies to C-C chemokine Receptor 3 ProteinBRIGHAM & WOMENS HOSPITAL·Filed 1997·Granted Mar 14, 2006·22 cites·149 claims
- 1871US2025295617A1Metabolites for treatment and prevention of autoimmune diseaseUNIV MONASH·Filed 2025·Application pending·0 cites
- 1969US10787510B2Methods of treating cancer using an IL-21 agonistUNIV MONASH·Filed 2018·Granted Sep 29, 2020·0 cites·11 claims
- 2069US7858326B2Method of diagnosis of inflammatory disease using eotaxin antibodiesMILLENNIUM PHARM INC·Filed 2008·Granted Dec 28, 2010·0 cites·7 claims
- 2167US2024262934A1Starch-indole-acid derivative, preparation method therefor, and use thereofSHANDONG SHANWEI IMMUNOTECH CO LTD·Filed 2024·Application pending·0 cites
- 2265US6323206B1Chemokine receptor antagonists and methods of use thereforMILLENNIUM PHARM INC·Filed 1998·Granted Nov 27, 2001·20 cites·19 claims
- 2365US6281212B1Chemokine receptor antagonists and methods of use thereforMILLENNIUM PHARM INC·Filed 1997·Granted Aug 28, 2001·23 cites·36 claims
- 2465US2021002362A1Il-21 binding proteins and uses thereofUNIV MONASH·Filed 2020·Application pending·0 cites
- 2564US2009220977A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 2662US10077301B2IL-21 binding proteinsUNIV MONASH·Filed 2014·Granted Sep 18, 2018·0 cites·10 claims
- 2762US9567398B2Antibody with specificity for GM-CSF (II)MAGNENAT LAURENT·Filed 2011·Granted Feb 14, 2017·1 cites·20 claims
- 2862US7265201B1Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 1995·Granted Sep 4, 2007·8 cites·5 claims
- 2960US8236933B2Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses thereforHERZOG HERBERT·Filed 2006·Granted Aug 7, 2012·1 cites·19 claims
- 3060US7285620B2Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 2005·Granted Oct 23, 2007·0 cites·18 claims
- 3160US2019167615A1Metabolites for treatment and prevention of autoimmune diseaseUNIV MONASH·Filed 2017·Application pending·0 cites
- 3259US7402657B2C-C chemokine receptor 3 proteinsMILLENNIUM PHARM INC·Filed 2005·Granted Jul 22, 2008·0 cites·16 claims
- 3358US2004019917A1NEOKINE protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3457US2006122373A1Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereofMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3557US2021244825A1Il-21 antibodiesUNIV MONASH·Filed 2021·Application pending·0 cites
- 3656US2006205034A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3755US2007043512A1Therapeutic and prophylactic compositions and uses thereforROLPH MICHAEL·Filed 2004·Application pending·0 cites
- 3854US2025270335A1Methods of treating inflammationUNIV MONASH·Filed 2025·Application pending·0 cites
- 3954US2002166133A1Neokine protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4053US6994977B2Method of identifying inhibitors of C—C chemokine receptor 3BRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Feb 7, 2006·0 cites·95 claims
- 4152US2010291579A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 4252US2008254030A1Use of Baff to Treat Th2-Mediated ConditionsMACKAY CHARLES·Filed 2006·Application pending·0 cites
- 4352US2003022279A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesFiled 2001·Application pending·0 cites
- 4451US2022049003A1Methods of treating inflammationUNIV MONASH·Filed 2019·Application pending·0 cites
- 4551US2024109971A1Ccr6 antibodiesUNIV MONASH·Filed 2021·Application pending·0 cites
- 4650US2006137029A1Novel G protein-coupled receptor encoding gene and diagnostic uses thereforG2 THERAPIES LTD·Filed 2005·Application pending·0 cites
- 4749US6806061B1G protein-coupled receptor gene and methods of use thereforCHILDRENS MEDICAL CENTER·Filed 1995·Granted Oct 19, 2004·6 cites·87 claims
- 4849US2012045777A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other usesFRASER CHRISTOPHER C·Filed 2011·Application pending·0 cites
- 4948US2010297135A1Epitope for neutralizing antibodiesCRC FOR ASTHMA AND AIRWAYS LTD·Filed 2008·Application pending·0 cites
- 5047US2022220202A1Combination therapy for treatment and prevention of autoimmune and inflammatory diseasesUNIV MONASH·Filed 2019·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles Mackay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →